Nu Skin Enterprises (NYSE:NUS) Updates FY 2026 Earnings Guidance

Nu Skin Enterprises (NYSE:NUS) issued an update on its FY 2026 earnings guidance on Monday morning. The company provided EPS guidance of 0.700-0.900 for the period, compared to the consensus estimate of 1.000. The company issued revenue guidance of $1.3 billion-$1.4 billion, compared to the consensus revenue estimate of $1.4 billion. Nu Skin Enterprises also updated its Q3 2026 guidance to 0.100-0.200 EPS.

Nu Skin Enterprises Price Performance

Nu Skin Enterprises stock traded down $0.33 during mid-day trading on Monday, hitting $5.16. 1,097,478 shares of the company were exchanged, compared to its average volume of 595,678. The company has a quick ratio of 1.34, a current ratio of 2.03 and a debt-to-equity ratio of 0.26. The business has a fifty day moving average of $5.22 and a 200 day moving average of $6.98. Nu Skin Enterprises has a 1-year low of $4.89 and a 1-year high of $14.62. The company has a market capitalization of $250.52 million, a PE ratio of 4.69 and a beta of 0.98.

Nu Skin Enterprises (NYSE:NUS) last issued its earnings results on Monday, August 10th. The company reported $0.20 EPS for the quarter, meeting the consensus estimate of $0.20. Nu Skin Enterprises had a net margin of 3.78% and a return on equity of 7.47%. The company had revenue of $320.11 million for the quarter, compared to the consensus estimate of $345.20 million. Nu Skin Enterprises has set its FY 2026 guidance at 0.700-0.900 EPS and its Q3 2026 guidance at 0.100-0.200 EPS. As a group, sell-side analysts expect that Nu Skin Enterprises will post 1 earnings per share for the current year.

Wall Street Analyst Weigh In

NUS has been the topic of a number of recent analyst reports. Weiss Ratings lowered shares of Nu Skin Enterprises from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Thursday, June 4th. Zacks Research raised shares of Nu Skin Enterprises from a “strong sell” rating to a “hold” rating in a report on Monday, April 13th. One investment analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Nu Skin Enterprises currently has an average rating of “Reduce”.

Institutional Investors Weigh In On Nu Skin Enterprises

Hedge funds have recently added to or reduced their stakes in the stock. Corient Private Wealth LLC bought a new position in shares of Nu Skin Enterprises in the fourth quarter worth about $166,000. Invesco Ltd. lifted its position in shares of Nu Skin Enterprises by 15.9% during the fourth quarter. Invesco Ltd. now owns 85,975 shares of the company’s stock worth $827,000 after purchasing an additional 11,810 shares in the last quarter. State of Tennessee Department of Treasury grew its stake in shares of Nu Skin Enterprises by 165.2% during the fourth quarter. State of Tennessee Department of Treasury now owns 30,835 shares of the company’s stock valued at $327,000 after purchasing an additional 19,210 shares during the last quarter. EP Wealth Advisors LLC bought a new stake in shares of Nu Skin Enterprises during the fourth quarter valued at approximately $692,000. Finally, Empowered Funds LLC increased its holdings in shares of Nu Skin Enterprises by 45.0% in the fourth quarter. Empowered Funds LLC now owns 241,670 shares of the company’s stock valued at $2,325,000 after purchasing an additional 74,945 shares in the last quarter. Institutional investors own 82.84% of the company’s stock.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc is a Utah-based direct selling company that develops and distributes personal care products and dietary supplements. Operating through a network marketing model, Nu Skin offers a portfolio of wellness, anti-aging skin care, hair care and nutritional products designed to support healthy living and appearance. The company leverages independent distributors to market its offerings directly to consumers across multiple channels, including online platforms and localized events.

Founded in 1984 by Blake M.